Search research articles
Contact Us
Filters
Showing results (631-640 of 671) with videos related to
Page
of 68
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 18, 2021
Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy
Mohammad H Al-Shaer, Kelly Maguigan, Jennifer Ashton, et al.
Antimicrobial Agents and Chemotherapy
|
March 16, 2021
Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy
Mohammad H Al-Shaer, Carolyn D Philpott, Christopher A Droege, et al.
AJNR. American Journal of Neuroradiology
|
August 23, 2000
Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model
J Butzen, R Prost, V Chetty, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2018
Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer
E T Van Matre, P M Reynolds, R MacLaren, et al.
The Journal of Experimental Medicine
|
January 2, 2013
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Qibin Zhang, Thomas L Fillmore, Athena A Schepmoes, et al.
The Journal of Surgical Research
|
April 2, 2018
Ketamine versus hydromorphone patient-controlled analgesia for acute pain in trauma patients
Sheila C Takieddine, Christopher A Droege, Neil Ernst, et al.
Journal of Proteome Research
|
December 21, 2007
Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset
Thomas O Metz, Wei-Jun Qian, Jon M Jacobs, et al.
Cell Death & Disease
|
April 29, 2016
CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
M Drachsler, S Kleber, A Mateos, et al.
Pharmacotherapy
|
June 16, 2018
A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients
Lynn E Kassel, Edward T Van Matre, Charles J Foster, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 19, 2017
Development of the Critical Care Pharmacotherapy Trials Network
Seth R Bauer, Prasad E Abraham, Jeffrey F Barletta, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 671) with videos related to
Sort By:
Page
of 68
Antimicrobial Agents and Chemotherapy
|
October 18, 2021
Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy
Mohammad H Al-Shaer, Kelly Maguigan, Jennifer Ashton, et al.
Antimicrobial Agents and Chemotherapy
|
March 16, 2021
Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy
Mohammad H Al-Shaer, Carolyn D Philpott, Christopher A Droege, et al.
AJNR. American Journal of Neuroradiology
|
August 23, 2000
Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model
J Butzen, R Prost, V Chetty, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2018
Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer
E T Van Matre, P M Reynolds, R MacLaren, et al.
The Journal of Experimental Medicine
|
January 2, 2013
Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Qibin Zhang, Thomas L Fillmore, Athena A Schepmoes, et al.
The Journal of Surgical Research
|
April 2, 2018
Ketamine versus hydromorphone patient-controlled analgesia for acute pain in trauma patients
Sheila C Takieddine, Christopher A Droege, Neil Ernst, et al.
Journal of Proteome Research
|
December 21, 2007
Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset
Thomas O Metz, Wei-Jun Qian, Jon M Jacobs, et al.
Cell Death & Disease
|
April 29, 2016
CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
M Drachsler, S Kleber, A Mateos, et al.
Pharmacotherapy
|
June 16, 2018
A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients
Lynn E Kassel, Edward T Van Matre, Charles J Foster, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 19, 2017
Development of the Critical Care Pharmacotherapy Trials Network
Seth R Bauer, Prasad E Abraham, Jeffrey F Barletta, et al.
Page
of 68